Startup Funding News Today, September 29, 2026: Atomic, Anote, Helix, Marble, Reverion & More
The latest funding report highlights significant capital movement in the biotech and health-tech sectors as of September 29, 2026. Among the notable developments, Milan-based biotech firm Aptadir Therapeutics secured a €40 million seed round to advance its work in RNA-based medicines, reflecting continued investor interest in therapeutic innovation.
HNH Insight
While the article focuses on broader biotech funding, it captures the current venture capital climate for health-related startups on the exact date of the request, providing a snapshot of the investment landscape for medical innovation.
Exchange Discussion
Join the expert conversation on this article in the HN&H Intelligence Exchange. Professional discussion only — cite your sources.
No comments yet.
